Equity Research-en

Equity Research

Dividend Growth Analysis | Accenture (ACN): Harmonizing 15 Years of Consecutive Dividend Growth and AI Booking Explosion Potential

by

TICKER: ACN Accenture (ACN) Dividend Investment Analysis Dividend Growth Analysis | Accenture (ACN): Harmonizing 15 Years of Consecutive Dividend Growth and AI Booking Explosion Potential 🏢 A. Business Overview (What They Do) Accenture plc is a leading global professional services company providing a broad range of services and solutions in strategy, consulting, digital, technology, and … Read more

Dividend Growth Stock Analysis | Verizon (VZ) — 24 Years of Consecutive Dividend Growth, Is Now the Time to Buy?

by

Verizon has maintained 24 consecutive years of dividend growth. With a forward yield of 6.08%, 5-year DGR of 1.95%, and a fair value of $69.62 based on a low P/E of 11.47x — the current price of $46.55 offers over 49% margin of safety, making it a strong buy for FIRE investors.

Realty Income (O) Analysis: The Ultimate Monthly Dividend Anchor for FIRE Portfolios

by

TICKER: O Realty Income (O) Dividend Investment Analysis 🏢 A. Business Overview (What They Do) Realty Income (O) is the world’s largest ‘Net Lease’ REIT, owning and managing over 13,000 commercial properties across the U.S., UK, and Europe. Its core strength lies in its “triple-net” structure, where tenants cover taxes, insurance, and maintenance, ensuring high … Read more

UnitedHealth Group (UNH) Analysis: Is the 50% Dip a Buying Opportunity? (Fair Value $349, BUY Signal)

by

TICKER: UNH UnitedHealth Group (UNH) Dividend Investment Analysis 26 Years of Consecutive Dividend Growth: Is the Historic Dip in the Healthcare Giant a Buying Opportunity? 🏢 A. Business Overview (What They Do) UnitedHealth Group (UNH) is the largest healthcare company in the U.S. by revenue, operating through two primary pillars. First is UnitedHealthcare — a … Read more